Chapter 22 : Macrolide, Quinolone, and Other Non-β-Lactam Antibiotic Resistance in

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Macrolide, Quinolone, and Other Non-β-Lactam Antibiotic Resistance in , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816537/9781555812973_Chap22-1.gif /docserver/preview/fulltext/10.1128/9781555816537/9781555812973_Chap22-2.gif


The emergence of resistance to penicillin and other beta-lactam antibiotics in pneumococci in the 1980s and 1990s led to the increased use of macrolides, fluoroquinolones, and other nonbetalactam antibiotics for pneumococcal infections. This chapter focuses on the molecular mechanisms of non-beta-lactam resistance in . Resistance to macrolides can occur by enzymatic inactivation, modification of the target by methylation or mutation, and active efflux. Proteins of the ABC transporter superfamily are organized such that two ATP-binding domains located cytoplasmically interact with two hydrophobic domains consisting of six to eight transmembrane domains. The esterase activity identified in hydrolyzed 14- and 16-membered macrolides. The primary targets of other quinolones have been determined; trovafloxacin, levofloxacin, and norfloxacin target topoisomerase IV (ParC), whereas the primary target of gatifloxacin is DNA gyrase (GyrA). The use of fluoroquinolones to treat pneumococcal infections is the most important factor in the emergence of fluoroquinolone resistance in . Inducible expression allows the mRNA to be made in an inactive conformation that becomes active by the presence of an inducing macrolide. In the United States, population-based surveillance for invasive disease showed that the rapid increase in macrolide resistance was correlated with the spread of mega in pneumococci. Exciting, recent data indicate that the total burden of antimicrobial resistance can be reduced by the use of pneumococcal conjugate vaccines that reduce colonization and transmission of the vaccine serotypes.

Citation: Ambrose K, Stephens D. 2004. Macrolide, Quinolone, and Other Non-β-Lactam Antibiotic Resistance in , p 350-366. In Tuomanen E, Mitchell T, Morrison D, Spratt B (ed), The Pneumococcus. ASM Press, Washington, DC. doi: 10.1128/9781555816537.ch22

Key Concept Ranking

Mobile Genetic Elements
Major Facilitator Superfamily
Upper Respiratory Tract Infections
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Ackermann, G.,, and A. C. Rodloff. 2003. Drugs of the 21st century: telithromycin (HMR 3647)—the first ketolide. J. Antimicrob. Chemother. 51:497511.
2. Adrian, P. V.,, and K. P. Klugman. 1997. Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41: 24062413.
3. Anderson, V. E.,, T. D. Gootz,, and N. Osheroff. 1998. Topoisomerase IV catalysis and the mechanism of quinolone action. J. Biol. Chem. 273:1787917885.
4. Ayoubi, P.,, A. O. Kilic,, and M. N. Vijayakumar. 1991. Tn5253, the pneumococcal omega (cat tet) BM6001 element, is a composite structure of two conjugative transposons, Tn 5251 and Tn 5252. J. Bacteriol. 173:16171622.
5. Ballester, S.,, P. Lopez,, J. C. Alonso,, M. Espinosa,, and S. A. Lacks. 1986. Selective advantage of deletions enhancing chloramphenicol acetyltransferase gene expression in Streptococcus pneumoniae plasmids. Gene 41:153163.
6. Bast, D. J.,, J. C. de Azavedo,, T. Y. Tam,, L. Kilburn,, C. Duncan,, L. A. Mandell,, R. J. Davidson,, and D. E. Low. 2001. Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:26312634.
7. Betriu, C.,, M. Redondo,, M. L. Palau,, A. Sanchez,, M. Gomez,, E. Culebras,, A. Boloix,, and J. J. Picazo. 2000. Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. Antimicrob. Agents Chemother. 44:18381841.
8. Black, S.,, and H. Shinefield. 1997. Issues and challenges: pneumococcal vaccination in pediatrics. Pediatr. Ann. 26:35560.
9. Breiman, R. F.,, J. C. Butler,, F. C. Tenover,, J. A. Elliott,, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:18311835.
10. Brenwald, N. P.,, M. J. Gill,, and R. Wise. 1998. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:20322035.
11. Brumfitt, W.,, and J. M. Hamilton-Miller. 1993. Reassessment of the rationale for the combinations of sulphonamides with diaminopyrimidines. J. Chemother. 5:465469.
12. Canu, A.,, B. Malbruny,, M. Coquemont,, T. A. Davies,, P. C. Appelbaum,, and R. Leclercq. 2002. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:125131.
13.Centers for Disease Control and Prevention. 2001. Resistance of Streptococcus pneumoniae to fluoroquinolones— United States, 1995-1999. Morb. Mortal. Wkly. Rep. 50:800804.
14. Chen, D. K.,, A. McGeer,, J. C. de Azavedo,, D. E. Low, and Canadian Bacterial Surveillance Network. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:233239.
15. Chopra, I.,, and M. Roberts. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65:232260.
16. Clancy, J.,, J. Petitpas,, F. Dib-Hajj,, W. Yuan,, M. Cronan,, A. V. Kamath,, J. Bergeron,, and J. A. Retsema. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867879.
17. Clewell, D. B.,, S. E. Flannagan,, Y. Ike,, J. M. Jones,, and C. Gawron-Burke. 1988. Sequence analysis of termini of conjugative transposon Tn916. J. Bacteriol. 170:30463052.
18. Clewell, D. B.,, S. E. Flannagan,, and D. D. Jaworski. 1995. Unconstrained bacterial promiscuity: the Tn916-Tn1545 family of conjugative transposons. Trends Microbiol. 3:229236.
19. Clewell, D. B.,, and C. Gawron-Burke. 1986. Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu. Rev. Microbiol. 40:635659.
20. Dagan, R.,, R. Melamed,, M. Muallem,, L. Piglansky,, D. Greenberg,, O. Abramson,, P. M. Mendelman,, N. Bohidar,, and P. Yagupsky. 1996. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J. Infect. Dis. 174:12711278.
21. David, F.,, G. de Cespedes,, F. Delbos,, and T. Horaud. 1993. Diversity of chromosomal genetic elements and gene identification in antibiotic- resistant strains of Streptococcus pneumoniae and Streptococcus bovis. Plasmid 29:147153.
22. Del Grosso, M.,, F. Iannelli,, C. Messina,, M. Santagati,, N. Petrosillo,, S. Stefani,, G. Pozzi,, and A. Pantosti. 2002. Macrolide efflux genes mef (A) and mef (E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40:774778.
23. Depardieu, F.,, and P. Courvalin. 2001. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:319323.
24. Doern, G. V. 2001. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin. Infect. Dis. 33(Suppl. 3):S187S192.
25. Doern, G. V.,, A. Brueggemann,, H. P. Holley, Jr.,, and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30- center national surveillance study. Antimicrob. Agents Chemother. 40:12081213.
26. Doern, G. V.,, K. P. Heilmann,, H. K. Huynh,, P. R. Rhomberg,, S. L. Coffman,, and A. B. Brueggemann. 2001. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:17211729.
27. Doherty, N.,, K. Trzcinski,, P. Pickerill,, P. Zawadzki,, and C. G. Dowson. 2000. Genetic diversity of the tet (M) gene in tetracycline- resistant clonal lineages of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 29792984.
28. Dowson, C. G.,, T. J. Coffey,, and B. G. Spratt. 1994. Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics. Trends Microbiol. 2:361366.
29. Eliopoulos, G. M. 2003. Quinupristin-dalfopristin and linezolid: evidence and opinion. Clin. Infect. Dis. 36:473481.
30. Enright, M.,, P. Zawadski,, P. Pickerill,, and C. G. Dowson. 1998. Molecular evolution of rifampicin resistance in Streptococcus pneumoniae. Microb. Drug Resist. 4:6570.
31. Flannagan, S. E.,, L. A. Zitzow,, Y. A. Su,, and D. B. Clewell. 1994. Nucleotide sequence of the 18-kb conjugative transposon Tn916 from Enterococcus faecalis. Plasmid 32:350354.
32. Fogarty, C. M.,, S. Kohno,, P. Buchanan,, M. Aubier,, and M. Baz. 2003. Communityacquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin. J. Antimicrob. Chemother. 51:947955.
33. Franke, A. E.,, and D. B. Clewell. 1981. Evidence for a chromosome-borne resistance transposon (Tn916) in Streptococcus faecalis that is capable of “conjugal” transfer in the absence of a conjugative plasmid. J. Bacteriol. 145:494502.
34. Fukuda, H.,, and K. Hiramatsu. 1999. Primary targets of fluoroquinolones in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43: 410412.
35. Gay, K.,, W. Baughman,, Y. Miller,, D. Jackson,, C. G. Whitney,, A. Schuchat,, M. M. Farley,, F. Tenover,, and D. S. Stephens. 2000. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6- year population-based assessment. J. Infect. Dis. 182:14171424.
36. Gay, K.,, and D. S. Stephens. 2001. Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. J. Infect. Dis. 184:5665.
37. Gill, M. J.,, N. P. Brenwald,, and R. Wise. 1999. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:187189.
38. Goldstein, E. J.,, and S. M. Garabedian-Ruffalo. 2002. Widespread use of fluoroquinolones versus emerging resistance in pneumococci. Clin. Infect. Dis. 35:15051511.
39. Gonzales, R.,, J. F. Steiner,, A. Lum,, and P. H. Barrett, Jr. 1999. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 281:15121519.
40. Gordon, K. A.,, M. L. Beach,, D. J. Biedenbach,, R. N. Jones,, P. R. Rhomberg,, and A. H. Mutnick. 2002. Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn. Microbiol. Infect. Dis. 43:157162.
41. Horinouchi, S.,, and B. Weisblum. 1982. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J. Bacteriol. 150:815825.
42. Hyde, T. B.,, K. Gay,, D. S. Stephens,, D. J. Vugia,, M. Pass,, S. Johnson,, N. L. Barrett,, W. Schaffner,, P. R. Cieslak,, P. S. Maupin,, E. R. Zell,, J. H. Jorgensen,, R. R. Facklam,, and C. G. Whitney. 2001. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 286:18571862.
43. Johnston, N. J.,, J. C. De Azavedo,, J. D. Kellner,, and D. E. Low. 1998. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae.Antimicrob. Agents Chemother. 42:24252426.
44. Jones, R. N.,, D. J. Farrell,, and I. Morrissey. 2003. Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 47:26962698.
45. Kilic, A. O.,, M. N. Vijayakumar,, and S. F. al-Khaldi. 1994. Identification and nucleotide sequence analysis of a transfer-related region in the streptococcal conjugative transposon Tn5252. J. Bacteriol. 176:51455150.
46. Kim, S.,, S. W. Lee,, E. C. Choi,, and S. Y. Choi. 2003. Aminoacyl-tRNA synthetases and their inhibitors as a novel family of antibiotics. Appl. Microbiol. Biotechnol. 61:278288.
47. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171196.
48. Klugman, K. P. 2003. The role of clonality in the global spread of fluoroquinolone-resistant bacteria. Clin. Infect. Dis. 36:783785.
49. Klugman, K. P. 2002. The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50(Suppl. S2):15.
50. Le Bouguenec, C.,, G. de Cespedes,, and T. Horaud. 1988. Molecular analysis of a composite chromosomal conjugative element (Tn3701) of Streptococcus pyogenes. J. Bacteriol. 170:39303936.
51. Le Bouguenec, C.,, G. de Cespedes,, and T. Horaud. 1990. Presence of chromosomal elements resembling the composite structure Tn3701 in streptococci. J. Bacteriol. 172:727734.
52. Leclercq, R.,, and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:12671272.
53. Leclercq, R.,, and P. Courvalin. 2002. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:27272734.
54. Linares, J.,, J. Garau,, C. Dominguez,, and J. L. Perez. 1983. Antibiotic resistance and serotypes of Streptococcus pneumoniae from patients with community-acquired pneumococcal disease. Antimicrob. Agents Chemother. 23:545547.
55. Linares, J.,, R. Pallares,, T. Alonso,, J. L. Perez,, J. Ayats,, F. Gudiol,, P. F. Viladrich,, and R. Martin. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99105.
56. Lonks, J. R.,, J. Garau,, and A. A. Medeiros. 2002. Implications of antimicrobial resistance in the empirical treatment of community-acquired respiratory tract infections: the case of macrolides. J. Antimicrob. Chemother. 50(Suppl. S2):8792.
57. Luna, V. A.,, P. Coates,, E. A. Eady,, J. H. Cove,, T. T. Nguyen,, and M. C. Roberts. 1999. A variety of gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44:925.
58. Luna, V. A.,, and M. C. Roberts. 1998. The presence of the tetO gene in a variety of tetracycline- resistant Streptococcus pneumoniae serotypes from Washington State. J. Antimicrob. Chemother. 42:613619.
59. Maskell, J. P.,, A. M. Sefton,, and L. M. Hall. 1997. Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:21212126.
60. Maskell, J. P.,, A. M. Sefton,, and L. M. Hall. 2001. Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:11041108.
61. Matsuoka, M.,, K. Endou,, H. Kobayashi,, M. Inoue,, and Y. Nakajima. 1998. A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol. Lett. 167:221227.
62. Mbelle, N.,, R. E. Huebner,, A. D. Wasas,, A. Kimura,, I. Chang,, and K. P. Klugman. 1999. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180:11711176.
63. McDougal, L. K.,, F. C. Tenover,, L. N. Lee,, J. K. Rasheed,, J. E. Patterson,, J. H. Jorgensen,, and D. J. LeBlanc. 1998. Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycinresistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:23122318.
64. Monro, R. E.,, and K. A. Marcker. 1967. Ribosome- catalysed reaction of puromycin with a formylmethionine-containing oligonucleotide. J. Mol. Biol. 25:347350.
65. Monro, R. E.,, and D. Vazquez. 1967. Ribosome- catalysed peptidyl transfer: effects of some inhibitors of protein synthesis. J. Mol. Biol. 28:161165.
66. Munoz-Najar, U.,, and M. N. Vijayakumar. 1999. An operon that confers UV resistance by evoking the SOS mutagenic response in streptococcal conjugative transposon Tn5252. J. Bacteriol. 181:27822788.
67. Musher, D. M.,, M. E. Dowell,, V. D. Shortridge,, R. K. Flamm,, J. H. Jorgensen,, P. Le Magueres,, and K. L. Krause. 2002. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N. Engl. J. Med. 346:630631.
68. Nagai, K.,, P. C. Appelbaum,, T. A. Davies,, L. M. Kelly,, D. B. Hoellman,, A. T. Andrasevic,, L. Drukalska,, W. Hryniewicz,, M. R. Jacobs,, J. Kolman,, J. Miciuleviciene,, M. Pana,, L. Setchanova,, M. K. Thege,, H. Hupkova,, J. Trupl,, and P. Urbaskova. 2002. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 Central and Eastern European countries. Antimicrob. Agents Chemother. 46:371377.
69. Norgren, M.,, and J. R. Scott. 1991. The presence of conjugative transposon Tn916 in the recipient strain does not impede transfer of a second copy of the element. J. Bacteriol. 173:319324.
70. Oggioni, M. R.,, C. G. Dowson,, J. M. Smith,, R. Provvedi,, and G. Pozzi. 1996. The tetracycline resistance gene tet(M) exhibits mosaic structure. Plasmid 35:156163.
71. Oster, P.,, A. Zanchi,, S. Cresti,, M. Lattanzi,, F. Montagnani,, C. Cellesi,, and G. M. Rossolini. 1999. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob. Agents Chemother. 43:25102512.
72. Padayachee, T.,, and K. P. Klugman. 1999. Molecular basis of rifampin resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:23612365.
73. Pan, X. S.,, and L. M. Fisher. 1997. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob. Agents Chemother. 41:471474.
74. Pelton, S. I.,, R. Dagan,, B. M. Gaines,, K. P. Klugman,, D. Laufer,, K. O’Brien,, and H. J. Schmitt. 2003. Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Vaccine 21:15621571.
75. Perez, J. L.,, J. Linares,, J. Bosch,, M. J. Lopez de Goicoechea,, and R. Martin. 1987. Antibiotic resistance of Streptococcus pneumoniae in childhood carriers. J. Antimicrob. Chemother. 19:278280.
76. Perkins, J. B.,, and P. J. Youngman. 1984. A physical and functional analysis of Tn917, a Streptococcus transposon in the Tn3 family that functions in Bacillus. Plasmid 12:119138.
77. Pestova, E.,, J. J. Millichap,, F. Siddiqui,, G. A. Noskin,, and L. R. Peterson. 2002. Non- PmrA-mediated multidrug resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 49: 553556.
78. Piddock, L. J.,, and M. M. Johnson. 2002. Accumulation of 10 fluoroquinolones by wildtype or efflux mutant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:813820.
79. Poyart-Salmeron, C.,, P. Trieu-Cuot,, C. Carlier,, and P. Courvalin. 1991. Nucleotide sequences specific for Tn1545-like conjugative transposons in pneumococci and staphylococci resistant to tetracycline. Antimicrob. Agents Chemother. 35:16571660.
80. Pozzi, G.,, R. A. Musmanno,, E. A. Renzoni,, M. R. Oggioni,, and M. G. Cusi. 1988. Host-vector system for integration of recombinant DNA into chromosomes of transformable and nontransformable streptococci. J. Bacteriol. 170:19691972.
81. Provvedi, R.,, R. Manganelli,, and G. Pozzi. 1996. Characterization of conjugative transposon Tn5251 of Streptococcus pneumoniae. FEMS Microbiol. Lett. 135:231236.
82. Reinert, R. R.,, A. Wild,, P. Appelbaum,, R. Lutticken,, M. Y. Cil,, and A. Al-Lahham. 2003. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany. Antimicrob. Agents Chemother. 47:23192322.
83. Rice, L. B. 2000. Bacterial monopolists: the bundling and dissemination of antimicrobial resistance genes in gram-positive bacteria. Clin. Infect. Dis. 31:762769.
84. Richter, S. S.,, K. P. Heilmann,, S. L. Coffman,, H. K. Huynh,, A. B. Brueggemann,, M. A. Pfaller,, and G. V. Doern. 2002. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clin. Infect. Dis. 34:330339.
85. Roberts, M. C.,, J. Sutcliffe,, P. Courvalin,, L. B. Jensen,, J. Rood,, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:28232830.
86. Rosato, A.,, H. Vicarini,, and R. Leclercq. 1999. Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin. J. Antimicrob. Chemother. 43: 559562.
87. Ross, J. I.,, E. A. Eady,, J. H. Cove,, and S. Baumberg. 1995. Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene 153:9398.
88. Ross, J. I.,, E. A. Eady,, J. H. Cove,, W. J. Cunliffe,, S. Baumberg,, and J. C. Wootton. 1990. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol. Microbiol. 4:12071214.
89. Salyers, A. A.,, N. B. Shoemaker,, A. M. Stevens,, and L. Y. Li. 1995. Conjugative transposons: an unusual and diverse set of integrated gene transfer elements. Microbiol. Rev. 59:579590.
90. Santagati, M.,, F. Iannelli,, M. R. Oggioni,, S. Stefani,, and G. Pozzi. 2000. Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44:25852587.
91. Schimmel, P.,, J. Tao,, and J. Hill. 1998. Aminoacyl tRNA synthetases as targets for new anti-infectives. FASEB J. 12:15991609.
92. Schlunzen, F.,, R. Zarivach,, J. Harms,, A. Bashan,, A. Tocilj,, R. Albrecht,, A. Yonath,, and F. Franceschi. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814821.
93. Schmitz, F. J.,, P. G. Higgins,, S. Mayer,, A. C. Fluit,, and A. Dalhoff. 2002. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur. J. Clin. Microbiol. Infect. Dis. 21:647659.
94. Schmitz, F. J.,, M. Perdikouli,, A. Beeck,, J. Verhoef,, and A. C. Fluit. 2001. Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates. Int. J. Antimicrob. Agents 18:433436.
95. Schrag, S. J.,, B. Beall,, and S. F. Dowell. 2000. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin. Microbiol. Rev. 13:588601.
96. Scott, J. R.,, P. A. Kirchman,, and M. G. Caparon. 1988. An intermediate in transposition of the conjugative transposon Tn916. Proc. Natl. Acad. Sci. USA 85:48094813.
97. Seppala, H.,, T. Klaukka,, J. Vuopio-Varkila,, A. Muotiala,, H. Helenius,, K. Lager,, P. Huovinen, and The Finnish Study Group for Antimicrobial Resistance. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337:441446.
98. Sessegolo, J. F.,, A. S. Levin,, C. E. Levy,, M. Asensi,, R. R. Facklam,, and L. M. Teixeira. 1994. Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992. J. Clin. Microbiol. 32:906911.
99. Shaw, J. H.,, and D. B. Clewell. 1985. Complete nucleotide sequence of macrolide-lincosamide- streptogramin B-resistance transposon Tn917 in Streptococcus faecalis. J. Bacteriol. 164:782796.
100. Shaw, W. V.,, and A. G. Leslie. 1991. Chloramphenicol acetyltransferase. Annu. Rev. Biophys. Biophys. Chem. 20:363386.
101. Shoemaker, N. B.,, M. D. Smith,, and W. R. Guild. 1980. DNase-resistant transfer of chromosomal cat and tet insertions by filter mating in Pneumococcus. Plasmid 3:8087.
102. Spika, J. S.,, R. R. Facklam,, B. D. Plikaytis,, M. J. Oxtoby, and The Pneumococcal Surveillance Working Group. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J. Infect. Dis. 163:12731278.
103. Sutcliffe, J.,, A. Tait-Kamradt,, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:18171824.
104. Swartley, J. S.,, C. F. McAllister,, R. A. Hajjeh,, D. W. Heinrich,, and D. S. Stephens. 1993. Deletions of Tn916-like transposons are implicated in tetM-mediated resistance in pathogenic Neisseria. Mol. Microbiol. 10:299310.
105. Syrogiannopoulos, G. A.,, I. N. Grivea,, A. Tait-Kamradt,, G. D. Katopodis,, N. G. Beratis,, J. Sutcliffe,, P. C. Appelbaum,, and T. A. Davies. 2001. Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece. Antimicrob. Agents Chemother. 45:342344.
106. Tait-Kamradt, A.,, J. Clancy,, M. Cronan,, F. Dib-Hajj,, L. Wondrack,, W. Yuan,, and J. Sutcliffe. 1997. mefE is necessary for the erythromycin- resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41: 22512255.
107. Tait-Kamradt, A.,, T. Davies,, P. C. Appelbaum,, F. Depardieu,, P. Courvalin,, J. Petitpas,, L. Wondrack,, A. Walker,, M. R. Jacobs,, and J. Sutcliffe. 2000. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 44:33953401.
108. Tait-Kamradt, A.,, T. Davies,, M. Cronan,, M. R. Jacobs,, P. C. Appelbaum,, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:21182125.
109. Tomich, P. K.,, F. Y. An,, and D. B. Clewell. 1980. Properties of erythromycin-inducible transposon Tn917 in Streptococcus faecalis. J. Bacteriol. 141:13661374.
110. Tomich, P. K.,, F. Y. An,, and D. B. Clewell. 1979. A transposon (Tn917) in Streptococcus faecalis that exhibits enhanced transposition during induction of drug resistance. Cold Spring Harbor Symp. Quant. Biol. 43(Pt. 2):12171221.
111. van Tilburg, P. M.,, D. Bogaert,, M. Sluijter,, A. R. Jansz,, R. de Groot,, and P. W. Hermans. 2001. Emergence of rifampin-resistant Streptococcus pneumoniae as a result of antimicrobial therapy for penicillin-resistant strains. Clin. Infect. Dis. 33:e93e96.
112. Vijayakumar, M. N.,, S. D. Priebe,, and W. R. Guild. 1986. Structure of a conjugative element in Streptococcus pneumoniae. J. Bacteriol. 166: 978984.
113. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577585.
114. Weisblum, B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39:797805.
115. Whitney, C. G.,, M. M. Farley,, J. Hadler,, L. H. Harrison,, N. M. Bennett,, R. Lynfield,, A. Reingold,, P. R. Cieslak,, T. Pilishvili,, D. Jackson,, R. R. Facklam,, J. H. Jorgensen,, and A. Schuchat. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:17371746.
116. Whitney, C. G.,, M. M. Farley,, J. Hadler,, L. H. Harrison,, C. Lexau,, A. Reingold,, L. Lefkowitz,, P. R. Cieslak,, M. Cetron,, E. R. Zell,, J. H. Jorgensen,, and A. Schuchat. 2000. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med 343:19171924.
117. Widdowson, C. A.,, P. V. Adrian,, and K. P. Klugman. 2000. Acquisition of chloramphenicol resistance by the linearization and integration of the entire staphylococcal plasmid pC194 into the chromosome of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 393395.
118. Widdowson, C. A.,, and K. P. Klugman. 1999. Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. Semin. Respir. Infect. 14:255268.
119. Widdowson, C. A.,, and K. P. Klugman. 1998. The molecular mechanisms of tetracycline resistance in the pneumococcus. Microb. Drug Resist. 4:7984.
120. Widdowson, C. A.,, K. P. Klugman,, and D. Hanslo. 1996. Identification of the tetracycline resistance gene, tet(O), in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:28912893.
121. Wu, S. W.,, H. de Lencastre,, and A. Tomasz. 1999. The Staphylococcus aureus transposon Tn551: complete nucleotide sequence and transcriptional analysis of the expression of the erythromycin resistance gene. Microb. Drug Resist. 5:17.
122. Zeller, V.,, C. Janoir,, M. D. Kitzis,, L. Gutmann,, and N. J. Moreau. 1997. Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:19731978.


Generic image for table

Molecular mechanisms of antibiotic resistance in

Citation: Ambrose K, Stephens D. 2004. Macrolide, Quinolone, and Other Non-β-Lactam Antibiotic Resistance in , p 350-366. In Tuomanen E, Mitchell T, Morrison D, Spratt B (ed), The Pneumococcus. ASM Press, Washington, DC. doi: 10.1128/9781555816537.ch22
Generic image for table

Genetic bases for antibiotic resistance in pneumococci

Citation: Ambrose K, Stephens D. 2004. Macrolide, Quinolone, and Other Non-β-Lactam Antibiotic Resistance in , p 350-366. In Tuomanen E, Mitchell T, Morrison D, Spratt B (ed), The Pneumococcus. ASM Press, Washington, DC. doi: 10.1128/9781555816537.ch22

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error